Traws Pharma Capital Expenditures (CapEx) Growth & History (TRAW)

Traws Pharma's capital expenditures (capex) was $2.6M for fiscal 2025.

View full Traws Pharma company overview

Traws Pharma annual capital expenditures (capex) history

Traws Pharma annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$2.6M−$1.1M−29.14%
20242024-12-31$3.6M$3.6M+25957.14%
20232023-12-31$14,000
20202020-12-31$15,000−$40,000−72.73%
20192019-12-31$55,000
20142014-12-31$228,000−$381,000−62.56%
20132013-12-31$609,000$330,000+118.28%
20122012-12-31$279,000$23,000+8.98%
20112011-12-31$256,000

Traws Pharma capital expenditures (capex) trends

Over the last five fiscal years, Traws Pharma's capital expenditures (capex) increased from $15,000 to $2.6M, a change of $2.6M. The latest reported quarter, Q3 2024, shows $0.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Traws Pharma source filings ↗

Community posts

It’s quiet here.

No posts about TRAW yet. Start the conversation.

Write the first post